CALM Stock Overview
Operates medical clinics. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Revitalist Lifestyle and Wellness Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.02 |
| 52 Week High | CA$0.12 |
| 52 Week Low | CA$0.015 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -80.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| CALM | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 1.3% |
| 1Y | -80.0% | 40.3% | 23.1% |
Return vs Industry: CALM underperformed the Canadian Healthcare industry which returned 4% over the past year.
Return vs Market: CALM underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| CALM volatility | |
|---|---|
| CALM Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CALM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CALM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Kathryn Walker | revitalist.com |
Revitalist Lifestyle and Wellness Ltd. operates medical clinics. The company offers ketamine-enhanced psychotherapy, psychedelic-enhanced psychotherapy, medicative infusion therapy, vitamin infusions, transcranial magnetic stimulation, psychotherapy, and other medications focusing on mental health and acupuncture.
Revitalist Lifestyle and Wellness Ltd. Fundamentals Summary
| CALM fundamental statistics | |
|---|---|
| Market cap | CA$2.75m |
| Earnings (TTM) | -CA$12.01m |
| Revenue (TTM) | CA$4.67m |
0.6x
P/S Ratio-0.2x
P/E RatioIs CALM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CALM income statement (TTM) | |
|---|---|
| Revenue | CA$4.67m |
| Cost of Revenue | CA$8.32m |
| Gross Profit | -CA$3.65m |
| Other Expenses | CA$8.36m |
| Earnings | -CA$12.01m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.087 |
| Gross Margin | -78.04% |
| Net Profit Margin | -256.86% |
| Debt/Equity Ratio | -140.6% |
How did CALM perform over the long term?
See historical performance and comparison